Godavari Drugs Peer Comparison

BSE: 530317

₹124.90

₹-1.26 (-1.00%)

As on 29-Sep-2026 09:53IST

Market cap

₹138 Cr

Revenue (TTM)

₹110 Cr

P/E Ratio

33.1

P/B Ratio

1.8

Div. Yield

0 %

Edit

	Godavari Drugs	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Market cap (₹ Cr)	138	21,684	20,012	18,151	17,148
Revenue (₹ Cr)	110	2,287	1,682	2,570	3,230
Net Profit (₹ Cr)	4.16	678.07	273.51	735.15	666.92
Net Margin (%)	3.75	28.10	16.19	26.88	20.60
RoE (%)	6.41	19.73	11.15	19.16	18.75
Price to Earnings	33.13	32.59	67.31	24.69	26.63
Price-To-Book	1.75	5.90	7.45	4.12	4.25

Income Statement (₹ Cr)

	Godavari Drugs	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Operating Revenue	109.95	2,287.33	1,682.47	2,569.77	3,229.67
Total Income	110.90	2,413.29	1,689.83	2,735.39	3,237.12
Total Expenditure	100.03	1,490.75	1,203.91	1,628.14	2,090.06
EBITDA	9.93	796.58	478.55	941.63	1,139.61
Depreciation	2.42	78.10	126.01	57.58	281.06
EBIT	7.51	718.48	352.55	884.05	858.55
Interest	3.87	0.88	52.11	7.69	190.64
Other Income	0.94	125.96	7.37	165.62	7.45
Exceptional Items	0.36	0.00	12.16	-49.16	-17.24
Profit before Tax	4.94	843.56	319.96	992.82	658.12
Provision for Tax	0.78	165.49	46.45	257.67	-8.80
Profit after Tax	4.16	678.07	273.51	735.15	666.92

	Godavari Drugs	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Shareholder's Funds	75.80	3,586.42	2,591.20	4,202.90	3,902.67
Minority Interest	0.00	-12.71	0.00	0.00	-21.81
Non-Current Liabilities	39.49	28.74	266.35	91.50	1,392.75
Current Liabilities	85.14	385.94	848.06	627.48	2,077.10
Total Liabilities	143.08	3,207.85	3,310.68	4,911.11	6,865.52

	Godavari Drugs	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Non-Current Assets	86.85	1,291.22	2,525.44	770.28	5,617.77
Current Assets	111.80	2,585.66	1,109.77	3,803.22	1,539.85
Total Assets	143.08	3,207.85	3,310.68	4,911.11	6,865.52
Total Debt*	64.35	0.55	586.37	2.50	2,421.66
Net Current Assets	26.65	2,199.72	261.71	3,175.74	-537.25
Contingent Liabilities	0.50	0.64	76.22	363.79	51.96

	Godavari Drugs	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Cash From Operating Activities	11.20	432.37	132.27	659.75	1,065.01
Cash Flow from Investing Activities	-19.51	-334.73	-199.13	-71.34	-79.97
Cash from Financing Activities	8.07	-38.32	62.65	-205.34	-881.32
Net Cash Inflow / Outflow	-0.25	59.32	-4.21	383.07	103.72

	Godavari Drugs	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
ROCE (%)	10.13	26.22	6.95	26.21	13.59
ROE (%)	6.41	19.73	11.15	19.16	18.75
ROA (%)	2.42	18.69	7.80	14.95	9.26
EBIT Margin (%)	6.83	31.41	20.95	34.40	26.58
Net Margin (%)	3.75	28.10	16.19	26.88	20.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Godavari Drugs	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Revenue Growth (%)	4.76	15.01	27.91	10.69	9.59
EBIT Growth (%)	-16.51	18.45	58.32	24.14	16.84
Net Profit Growth (%)	9.69	19.61	149.56	-9.09	62.68
EPS Growth (%)	-13.09	17.73	-3.57	14.40	67.41
Book Value Growth (%)	11.24	23.77	30.63	17.30	10.19

	Godavari Drugs	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Price / Earnings	28.85	32.59	71.40	23.53	25.96
Price / Book Value	1.75	5.90	7.45	4.12	4.25
Dividend Yield (%)	0.00	0.28	0.06	1.89	0.00
EV/EBITDA	20.11	25.96	43.10	15.98	17.02
Market Cap (₹ Cr)	65.86	15,219.80	6,484.12	18,318.10	19,292.77

	Godavari Drugs	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Debt to Equity	0.49	0.00	0.07	0.00	0.24
Short term debt to equity ratio	0.87	0.00	0.13	0.00	0.14
Current Ratio	1.31	6.70	1.31	6.06	0.74
Quick Ratio	0.77	5.59	0.88	5.31	0.53
Interest Coverage	2.28	959.59	7.14	130.11	4.45

	Godavari Drugs	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Debtors to sales (%)	39.64	36.10	30.84	7.07	21.07
Asset Turnover	0.64	0.63	0.48	0.52	0.45
Receivable days	163.82	110.70	118.15	29.10	54.06
Inventory Days	78.24	65.86	98.29	69.53	32.16
Payable days	134.84	105.88	128.16	76.77	140.91
Cash Conversion Cycle	107.21	70.68	88.28	21.86	-54.69

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.